{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T11:43:16Z","timestamp":1782128596638,"version":"3.54.5"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.neurobiolaging.2021.01.022","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T01:45:41Z","timestamp":1612489541000},"page":"199-206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Different patterns of \u03b2-amyloid deposition in patients with Alzheimer's disease according to the presence of mild parkinsonism"],"prefix":"10.1016","volume":"101","author":[{"given":"Seok Jong","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1982-2605","authenticated-orcid":false,"given":"Sangwon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Soo","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KyoungWon","family":"Baik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6328-6948","authenticated-orcid":false,"given":"Hye Sun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Ho","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghoon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Man","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Joong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byoung Seok","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young H.","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mijin","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9931-8462","authenticated-orcid":false,"given":"Phil Hyu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0001","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1212\/01.wnl.0000249130.63615.cc","article-title":"Differences in neuropathologic characteristics across the Lewy body dementia spectrum","volume":"67","author":"Ballard","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0002","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00401-009-0522-3","article-title":"Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease","volume":"118","author":"Bell","year":"2009","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0003","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1212\/WNL.0000000000003059","article-title":"Incident parkinsonism in older adults without Parkinson disease","volume":"87","author":"Buchman","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0004","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/gerona\/glv153","article-title":"Parkinsonism in older adults and its association with adverse health outcomes and neuropathology","volume":"71","author":"Buchman","year":"2016","journal-title":"J Gerontol Ser A Biol Sci Med Sci"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0005","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1212\/WNL.0b013e318294b462","article-title":"Association of brain pathology with the progression of frailty in older adults","volume":"80","author":"Buchman","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0006","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1212\/01.WNL.0000158423.05224.7F","article-title":"The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs","volume":"64","author":"Burns","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0007","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00702-004-0140-0","article-title":"Presynaptic nigro-striatal function in a group of Alzheimer's disease patients with parkinsonism: evidence from a dopamine transporter imaging study","volume":"111","author":"Ceravolo","year":"2004","journal-title":"J Neural Transm"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0008","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/mds.20844","article-title":"International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson\u2019s disease: the NMSQuest study","volume":"21","author":"Chaudhuri","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0009","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1001\/archneur.1991.00530230049020","article-title":"Cumulative risks of developing extrapyramidal signs, psychosis, or myoclonus in the course of Alzheimer's disease","volume":"48","author":"Chen","year":"1991","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0010","first-page":"585","article-title":"Estimating the Validity of the Korean Version of Expanded Clinical Dementia Rating (CDR) Scale","volume":"19","author":"Choi","year":"2001","journal-title":"J Korean Neurol Assoc"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0011","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/ana.25179","article-title":"Do subjects with minimal motor features have prodromal Parkinson disease?","volume":"83","author":"Chu","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0012","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1001\/archneur.1994.00540190056015","article-title":"Extrapyramidal signs and psychiatric symptoms predict faster cognitive decline in Alzheimer's disease","volume":"51","author":"Chui","year":"1994","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0013","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1007\/s00259-019-04315-6","article-title":"Distinct FP-CIT PET patterns of Alzheimer's disease with parkinsonism and dementia with Lewy bodies","volume":"46","author":"Chung","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0014","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/ana.410260302","article-title":"Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease","volume":"26","author":"de la Monte","year":"1989","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0015","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol Neurodegeneration"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0016","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1212\/01.wnl.0000244749.20056.d4","article-title":"Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study","volume":"68","author":"Edison","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0017","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jnnp.52.2.193","article-title":"The substantia nigra and ventral tegmental area in Alzheimer's disease and Down's syndrome","volume":"52","author":"Gibb","year":"1989","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0018","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.410410106","article-title":"Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease","volume":"41","author":"Gomez-Isla","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0019","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1212\/01.wnl.0000326146.60732.d6","article-title":"Imaging amyloid deposition in Lewy body diseases","volume":"71","author":"Gomperts","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0020","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1016\/j.neurobiolaging.2012.01.016","article-title":"White matter hyperintensities predict amyloid increase in Alzheimer's disease","volume":"33","author":"Grimmer","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0021","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1212\/WNL.0000000000004643","article-title":"vivo staging of regional amyloid deposition","volume":"89","author":"Grothe","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0022","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neurobiolaging.2019.10.007","article-title":"Presynaptic dopaminergic function in early-onset Alzheimer's disease: an FP-CIT image study","volume":"86","author":"Jang","year":"2020","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0023","doi-asserted-by":"crossref","first-page":"16178","DOI":"10.1038\/s41598-018-34032-3","article-title":"Distinct amyloid distribution patterns in amyloid positive subcortical vascular cognitive impairment","volume":"8","author":"Jang","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0024","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ana.21164","article-title":"Imaging of amyloid burden and distribution in cerebral amyloid angiopathy","volume":"62","author":"Johnson","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0025","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ana.21223","article-title":"Beta-amyloid burden is not associated with rates of brain atrophy","volume":"63","author":"Josephs","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0026","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/mds.870120609","article-title":"Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson\u2019s, Alzheimer\u2019s with parkinsonism, and Alzheimer\u2019s disease","volume":"12","author":"Joyce","year":"1997","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0027","series-title":"Seoul Neuropsychological Screening Battery (SNSB-II)","author":"Kang","year":"2012"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0028","first-page":"300","article-title":"A validity study on the korean mini-mental state examination (K-MMSE) in dementia patients","volume":"15","author":"Kang","year":"1997","journal-title":"J Korean Neurol Assoc"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0029","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1212\/WNL.0000000000008818","article-title":"beta-Amyloid PET and neuropathology in dementia with Lewy bodies","volume":"94","author":"Kantarci","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0030","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.neurobiolaging.2009.07.002","article-title":"Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI","volume":"32","author":"Landau","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0031","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1212\/WNL.0000000000008812","article-title":"Can amyloid PET differentiate \"pure\" LBD from AD with or without LBD copathology?","volume":"94","author":"Landau","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0032","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nature07761","article-title":"Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers","volume":"457","author":"Lauren","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0033","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/WNL.0000000000001999","article-title":"Is normosmic Parkinson disease a unique clinical phenotype?","volume":"85","author":"Lee","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0034","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/1531-8257(200011)15:6<1221::AID-MDS1024>3.0.CO;2-H","article-title":"The validity of the Beck Depression Inventory as a screening and diagnostic instrument for depression in patients with Parkinson\u2019s disease","volume":"15","author":"Leentjens","year":"2000","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0035","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/brain\/aws327","article-title":"Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer\u2019s disease","volume":"136","author":"Lehmann","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0036","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/ana.410410312","article-title":"Pathological correlates of extrapyramidal signs in Alzheimer's disease","volume":"41","author":"Liu","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0037","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/bmj.305.6855.673","article-title":"Neuroleptic sensitivity in patients with senile dementia of Lewy body type","volume":"305","author":"McKeith","year":"1992","journal-title":"BMJ"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0038","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1474-4422(07)70057-1","article-title":"Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study","volume":"6","author":"McKeith","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0039","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0040","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1136\/jnnp.57.12.1503","article-title":"Extrapyramidalism in Alzheimer's disease: prevalence, psychiatric, and neuropsychological correlates","volume":"57","author":"Merello","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0041","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3988\/jcn.2009.5.4.153","article-title":"Current challenges for the early detection of Alzheimer\u2019s Disease: brain imaging and CSF studies","volume":"5","author":"Mistur","year":"2009","journal-title":"J Clin Neurol (Seoul, Korea)"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0042","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/archneur.1989.00520420071025","article-title":"Clinical and pathological aspects of parkinsonism in Alzheimer's disease. A role for extranigral factors?","volume":"46","author":"Morris","year":"1989","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0043","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S1474-4422(17)30074-1","article-title":"The prognosis of dementia with Lewy bodies","volume":"16","author":"Mueller","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0044","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1212\/WNL.61.7.944","article-title":"The impact of parkinsonism on costs of care in patients with AD and dementia with Lewy bodies","volume":"61","author":"Murman","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0045","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/ana.410370306","article-title":"Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism","volume":"37","author":"Murray","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0046","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/archneurol.2010.280","article-title":"Functional impact of white matter hyperintensities in cognitively normal elderly subjects","volume":"67","author":"Murray","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0047","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.3233\/JAD-190625","article-title":"Florbetapir regional distribution in cerebral amyloid angiopathy and Alzheimer\u2019s disease: a PET study","volume":"73","author":"Planton","year":"2020","journal-title":"J Alzheimer\u2019s Dis"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0048","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/archneurol.2009.196","article-title":"Extrapyramidal signs before and after diagnosis of incident Alzheimer disease in a prospective population study","volume":"66","author":"Portet","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0049","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0197-4580(88)80061-7","article-title":"Dopaminergic system and monoamine oxidase-B activity in Alzheimer's disease","volume":"9","author":"Reinikainen","year":"1988","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0050","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1212\/WNL.50.1.152","article-title":"Striatal uptake of the dopamine reuptake ligand [11C]beta-CFT is reduced in Alzheimer's disease assessed by positron emission tomography","volume":"50","author":"Rinne","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0051","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.2967\/jnumed.115.168732","article-title":"Comparison of Early-Phase 11C-Deuterium-l-Deprenyl and 11C-Pittsburgh Compound B PET for Assessing Brain Perfusion in Alzheimer Disease","volume":"57","author":"Rodriguez-Vieitez","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0052","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40336-015-0102-6","article-title":"Beta-amyloid imaging with florbetaben","volume":"3","author":"Sabri","year":"2015","journal-title":"Clin Transl Imaging"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0053","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/1099-1166(200009)15:9<794::AID-GPS178>3.0.CO;2-1","article-title":"Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study","volume":"15","author":"Samuel","year":"2000","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2018.06.3054","article-title":"High prevalence of parkinsonism in patients with MCI or mild Alzheimer\u2019s disease","author":"Sasaki","year":"2018","journal-title":"Alzheimer\u2019s Dementia"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0055","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1212\/01.WNL.0000162054.15428.E9","article-title":"Motor signs predict poor outcomes in Alzheimer disease","volume":"64","author":"Scarmeas","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0056","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1212\/01.WNL.0000138440.39918.0C","article-title":"Motor signs during the course of Alzheimer disease","volume":"63","author":"Scarmeas","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0057","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0022-510X(93)90041-V","article-title":"A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging","volume":"114","author":"Scheltens","year":"1993","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0058","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3389\/fnagi.2018.00158","article-title":"Using CT data to improve the quantitative analysis of (18)F-FBB PET neuroimages","volume":"10","author":"Segovia","year":"2018","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0059","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory","volume":"14","author":"Shankar","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0060","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1177\/089198879500800302","article-title":"Study of Alzheimer's dementia patients with parkinsonian features","volume":"8","author":"Snowden","year":"1995","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0061","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1212\/WNL.44.12.2300","article-title":"Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the Predictors Study","volume":"44","author":"Stern","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0062","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/2051-5960-1-65","article-title":"Clinical and multimodal biomarker correlates of ADNI neuropathological findings","volume":"1","author":"Toledo","year":"2013","journal-title":"Acta Neuropathologica Commun"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0063","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1212\/WNL.0000000000002082","article-title":"Cerebral small vessel disease and incident parkinsonism: The RUN DMC study","volume":"85","author":"van der Holst","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0064","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000441919","article-title":"Cerebral beta-amyloid angiopathy is associated with earlier dementia onset in Alzheimer\u2019s disease","volume":"16","author":"Vidoni","year":"2016","journal-title":"Neuro-Degenerative Dis"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0065","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/archneur.57.6.855","article-title":"Progression of parkinsonism and loss of cognitive function in Alzheimer disease","volume":"57","author":"Wilson","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0066","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1468-1331.2007.01977.x","article-title":"A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies","volume":"14","author":"Yong","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurobiolaging.2021.01.022_bib0067","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/ana.25707","article-title":"Dopaminergic Depletion, beta-Amyloid Burden, and Cognition in Lewy Body Disease","volume":"87","author":"Yoo","year":"2020","journal-title":"Ann Neurol"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458021000294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458021000294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:37:06Z","timestamp":1759318626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458021000294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":67,"alternative-id":["S0197458021000294"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.01.022","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Different patterns of \u03b2-amyloid deposition in patients with Alzheimer's disease according to the presence of mild parkinsonism","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}